Melissa Alcox, PA
Physician Assistant · Norfolk, VANPI 1790738029
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. E.r. Squibb & Sons, L.L.C. accounts for 66.7% of it on its own, with 32 other manufacturers making up the rest. Among physician assistant clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 929 payments — averaging $78.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$48K
- Arcutis Biotherapeutics, Inc.$7K
- AbbVie$4K
- Johnson & Johnson$2K
- Amgen$2K
- LEO Pharma Inc.$2K
- plus $8K from 27 others
What the payments were for
- Consulting fees$13,53819%
- Speaking & faculty fees$28,89040%
- Travel & lodging$9,69413%
- Food & beverage$20,16428%
- Education$3370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 147 | $48,466 |
| Arcutis Biotherapeutics, Inc. | 52 | $6,796 |
| AbbVie(2 entities) | 183 | $3,761 |
| Johnson & Johnson | 74 | $2,492 |
| Amgen | 54 | $1,621 |
| LEO Pharma Inc. | 63 | $1,529 |
| Sanofi | 57 | $1,143 |
| UCB, Inc. | 45 | $1,134 |
| Galderma Laboratories, L.p. | 68 | $995 |
| Botanix SB Inc | 7 | $881 |
| Lilly USA, LLC | 39 | $749 |
| Sun Pharmaceutical Industries Inc. | 37 | $624 |
| Pfizer | 27 | $621 |
| Novartis | 22 | $500 |
| Incyte Corporation | 13 | $306 |
| Regeneron Healthcare Solutions, Inc. | 3 | $142 |
| VYNE Pharmaceuticals Inc. | 1 | $114 |
| Revance Therapeutics, Inc. | 4 | $100 |
| Boehringer Ingelheim | 4 | $100 |
| Biofrontera Inc. | 5 | $99 |
| Organon | 5 | $86 |
| Dermavant Sciences, Inc. | 4 | $76 |
| Kyowa Kirin, Inc. | 3 | $61 |
| Blueprint Medicines Corporation | 2 | $38 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $32 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $31 |
| Springworks Therapeutics, Inc. | 1 | $30 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Dermira, Inc. | 1 | $18 |
| Merck | 1 | $17 |
| LNHC, Inc | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Stemline Therapeutics Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$72,622 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 13 | $64,947 |
| Ketoconazole | 129 | $3,973 |
| Fluorouracil | 45 | $2,940 |
| Clobetasol Propionate | 44 | $2,555 |
| Pimecrolimus | 11 | $2,387 |
| Tretinoin | 21 | $1,717 |
| Metronidazole | 22 | $1,006 |
| Clindamycin Phosphate | 22 | $690 |
| Doxycycline Hyclate | 14 | $589 |
| Triamcinolone Acetonide | 68 | $477 |
| Betamethasone Dipropionate | 19 | $424 |
| ValacyclovirValacyclovir Hcl | 17 | $190 |
| Hydrocortisone | 30 | $165 |
| Ammonium Lactate | 11 | $160 |
| Minoxidil | 24 | $156 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $1,621 | $64,94713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Norfolk
- Hillary HartungNorfolk$62K
- Stephanie HadleyNorfolk$15K
- Danielle JohnsonNorfolk$13K
- Ericka ThompsonNorfolk$13K
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Lindsay TomReston$71K
- Robert HigginsonRichmond$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.